Development of a novel lipid metabolism-based risk score model in hepatocellular carcinoma patients

BACKGROUND: Liver cancer is one of the most common malignancies worldwide. HCC (hepatocellular carcinoma) is the predominant pathological type of liver cancer, accounting for approximately 75–85 % of all liver cancers. Lipid metabolic reprogramming has emerged as an important feature of HCC. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wenjie, Zhang, Chen, Yu, Qihong, Zheng, Xichuan, Yin, Chuanzheng, Yan, Xueke, Liu, Gang, Song, Zifang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881464/
https://www.ncbi.nlm.nih.gov/pubmed/33579192
http://dx.doi.org/10.1186/s12876-021-01638-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881464/
https://www.ncbi.nlm.nih.gov/pubmed/33579192
http://dx.doi.org/10.1186/s12876-021-01638-3

Ejemplares similares